Technical and Regulatory Considerations for Designing Next-Generation Sequencing Controls and Standards for Optimal Quality and Performance: A Panel Discussion

February 11, 2020

Technical and Regulatory Considerations for Designing Next-Generation Sequencing Controls and Standards for Optimal Quality and Performance: A Panel Discussion

Partner Webinar

Join or Log in for Access

This content is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technical and Regulatory Considerations for Designing Next-Generation Sequencing Controls and Standards for Optimal Quality and Performance: A Panel Discussion.

Presented by Russell Garlick PhD - CSO LGC Clinical Diagnostics SeraCare LIfe Sciences
Karen Gutekunst PhD - VP of Regulatory Affairs Illumina
Bob Daber PhD - President and CTO Genosity
Federico Goodsend PhD - Principal Regulatory Pathfinders LLC
Jinjie Hu PhD - Principal Consultant for Axteria BioMed

Menu